The University of Chicago Header Logo

Connection

Kenneth Gordon to Rheumatic Diseases

Back to Details
This is a "connection" page, showing publications Kenneth Gordon has written about Rheumatic Diseases.
Kenneth Gordon
Connection Strength
0.105
Rheumatic Diseases
  1. Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease. Ann Rheum Dis. 2013 Apr; 72(4):517-24.
    View in: PubMed
    Score: 0.105
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.